These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 6276638)
61. Hepatitis A virus immunoglobulin M antibody in acute neurological disease. Bosch VV; Dowling PC; Cook SD Ann Neurol; 1983 Dec; 14(6):685-7. PubMed ID: 6316838 [TBL] [Abstract][Full Text] [Related]
62. False positive results occurring in a radioimmunoassay for hepatitis A IgM antibody of the IgM class. Bucens MR; Pietroboni GR; Harnett GB J Virol Methods; 1983 Dec; 7(5-6):287-95. PubMed ID: 6330147 [TBL] [Abstract][Full Text] [Related]
63. Indirect immunofluorescence assay for the detection of hepatitis A virus-specific serum immunoglobulins. Anderson DA; Coulepis AG; Chenoweth MP; Gust ID J Clin Microbiol; 1986 Jul; 24(1):163-5. PubMed ID: 3013929 [TBL] [Abstract][Full Text] [Related]
64. [Sero-epidemiological characterization of a hepatitis A epidemic associated with a child day care center for a Kuna Indian population in San Blas]. Betts C; Jaramillo A Rev Med Panama; 1984 Jan; 9(1):26-34. PubMed ID: 6322243 [No Abstract] [Full Text] [Related]
65. [Epidemiological patterns in the spread of hepatitis A and the means for improving the measures for controlling this infection]. Aleĭnik MD Zh Mikrobiol Epidemiol Immunobiol; 1985 May; (5):58-63. PubMed ID: 2994328 [No Abstract] [Full Text] [Related]
66. [The hepatitis A virus antibody (anti-HAV) in chronic diffuse liver diseases]. Dávid K; Halmy L Orv Hetil; 1983 May; 124(21):1241-3. PubMed ID: 6308536 [No Abstract] [Full Text] [Related]
67. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine. Vidor E; Xueref C; Blondeau C; Bajard A; Francon A; Goudeau A; Peyron F; Brasseur P; Zuckerman A Biologicals; 1996 Sep; 24(3):235-42. PubMed ID: 8978923 [TBL] [Abstract][Full Text] [Related]
68. [Epidemic of viral hepatitis in a mountain community of western Sicily]. Intonazzo V; La Rosa G; Lanza A; Famà B; Vazzana G; Romano N; Oliveri R Boll Ist Sieroter Milan; 1982 May; 61(2):144-50. PubMed ID: 6289849 [TBL] [Abstract][Full Text] [Related]
69. [Value of the determination of anti-HAV IgM in the diagnosis of hepatitis A]. Portell A; Pedreira JD; Vargas V; Hernández JM; Jardí R; Esteban R; Guardia J Med Clin (Barc); 1984 Mar; 82(12):519-21. PubMed ID: 6738150 [No Abstract] [Full Text] [Related]
70. [A case of severe hepatitis A with positive IgM antibody to hepatitis A virus of long duration, monoclonal gammopathy (IgG.lambda) and hemolytic anemia]. Fukatani Y; Numata Y; Kumon Y; Yoshida K; Yamamoto M; Suehiro T; Yamano T; Ohno F Nihon Naika Gakkai Zasshi; 1989 Apr; 78(4):573-4. PubMed ID: 2545803 [No Abstract] [Full Text] [Related]
71. [Incidence and the clinical variants of serologically confirmed viral hepatitis A in children]. Reĭzis AR; Drondina AK; Astratian AA; Danilina GA; Mardanly SG Pediatriia; 1987; (7):72-7. PubMed ID: 2823213 [No Abstract] [Full Text] [Related]
72. The selection of Danish blood donors according to sex and age in order to secure adequate content of immunoglobulin against hepatitis A and B in pooled plasma. Sørensen PG; Tønnesen E; Diederichsen H; Matinussen K Dan Med Bull; 1983 Nov; 30(6):421-4. PubMed ID: 6315313 [No Abstract] [Full Text] [Related]
73. [An evaluation of the possibility of using saliva as a substrate for the specific diagnosis of hepatitis A]. Chikovitova NM; Aleĭnik MD; Sivukhina NI Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):109-10. PubMed ID: 8079525 [No Abstract] [Full Text] [Related]
74. [Hepatitis A virus antibodies in children]. Nikolić P; Nikolić S; Bajić V; Obradović D Srp Arh Celok Lek; 1981 Mar; 109(3):363-70. PubMed ID: 6285526 [No Abstract] [Full Text] [Related]
75. [Antibodies to hepatitis A and B in healthy children, mentally retarded children in institutions, and in employees of a children's hospital]. Bosch C; Frösner GG; Rotthauwe HW Klin Padiatr; 1982; 194(6):393-6. PubMed ID: 6296529 [No Abstract] [Full Text] [Related]
76. [A relapsing and protracted form of viral hepatitis A: comparison of adults and children]. Stránský J; Honzáková E; Vandasová J; Kyncl J Vnitr Lek; 1995 Aug; 41(8):525-30. PubMed ID: 7483334 [TBL] [Abstract][Full Text] [Related]
77. [Selection of the specific components for setting up the immunoenzyme method to detect hepatitis A virus markers]. Mardanly SG; Vasil'eva VI; Rybalkina TN; Danilina GA; Avdina AI Lab Delo; 1986; (5):294-6. PubMed ID: 2425139 [No Abstract] [Full Text] [Related]
78. Frequency of inapparent hepatitis A infection. Coursaget P; Lesage G; Yvonnet B; Goudeau A; Maupas P Biomedicine; 1980 Dec; 33(8):246-7. PubMed ID: 7213922 [TBL] [Abstract][Full Text] [Related]
79. [The results of a controlled field trial of a dried erythrocytic immunoglobulin diagnostic agent for detecting the hepatitis A virus antigen]. Gorbunov MA; Nikitiuk NM; Solov'ev IuF; Karpovich LG; Kalashnikova TV; Reĭzis AR; Anan'ev VA; Doroshenko NV; Donets MA; Favorov MO Zh Mikrobiol Epidemiol Immunobiol; 1991 Nov; (11):43-5. PubMed ID: 1667348 [TBL] [Abstract][Full Text] [Related]
80. [Seroepidemiology of hepatitis A infection in children in Taiwan]. Wu TC; Hsieh KS; Wang HC; Wong YL; Shiao IS; Kwan SH; Yeh SH Taiwan Yi Xue Hui Za Zhi; 1982 Aug; 81(8):1012-6. PubMed ID: 6294216 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]